 Wysłany: Śro 10:19, 16 Mar 2011 Temat postu: MBT schuhe preise qur hmr zin mmp |
|
| Diversification of our business strategy of pharmaceutical companies
Value of 50% or more. Preoperative ECG: right bundle branch block completely in 6 cases, occasional ventricular premature in 2 cases, atrial fibrillation 2 cabinet case left pneumonectomy I1.2 surgical resection in 45 cases, resection of right pneumonectomy l9 cases, 26 cases handled by the pericardium blood vessels, including handling by the pericardium, inferior pulmonary vein l2 cases, treatment pulmonary artery and vein in 5 cases, 9 cases of partial resection of the left atrium. One case of partial esophageal muscular layer; half carina resection in 2 cases. Intraoperative see above, under the pulmonary vein thrombosis in 6 patients, nodules were sutured bronchial stump, pleura embedded bronchial stump in 51 cases. All groups underwent mediastinal lymph node dissection,MBT schuhe preise, 56 cases of hate rule resection (87.5%), palliative resection in 8 cases (12.5%), of which 6 cases of carcinoma of the trachea stump pneumonectomy reasons: pulmonary artery by invasion 2l cases, 33 cases of primary bronchial involvement, pulmonary artery injury in 4 cases. 1.3 pathological type and P-TNM staging of 40 cases of squamous cell carcinoma, adenocarcinoma 18 cases, adenosquamous carcinoma in 3 cases, 2 cases of large cell carcinoma, small cell carcinoma in 1 case, Ⅱ stage in 4 cases, Ⅲ a period of 36 cases , Ⅲ b of the 23 cases, Ⅳ of the l cases. Complications of atrial fibrillation and other arrhythmias 1.4 in 11 cases, empyema in 2 cases, 1 case of cerebral embolism, killed in 2 cases. Operative mortality of 3%. Arrhythmia and Nie embolism,mbt scarpe, was discharged after treatment, disease transfer. 2 cases of empyema, the drainage and anti-inflammatory treatment improved, but long-term with closed thoracic drainage tube. 1.5 Adjuvant medical treatments in the whole group 42 patients 2 years after the line C0M, MVP, NP, CAP and other chemotherapy ranged from 2 to 8 cycles. l3 postoperative chest radiotherapy cobalt 60 or linear accelerator 40 ~ 50Gy. 2. The results were followed up 58 patients: postoperative follow-up rate was 90.6%, after 1-year survival rate 92.4% (42/5  , 3-year survival rate of 34.28% (12/35), 5-year survival rate 25% (5 / 20), survival l0 years in 2 cases, 2 cases 8 years, 6 years in 1 case. 3. Graham in 1933 to discuss the successful implementation of all lung resection, open surgical treatment of lung cancer. ... Lobectomy nearly three decades has been replaced by whole lung resection, and become the standard surgical treatment of lung cancer were selected. Bronchial sleeve angioplasty carried out to make some heart and lung dysfunction in patients with lung cancer receive surgical root rule of the opportunities, but also power, especially financial strength,tory burch reva, is the diversification of the basic guarantee for the success of one, and only the strength of the enterprise Diversification can be implemented only 『lI. If the enterprise with limited resources, it is possible for enterprises to adopt the equipment behind, or smaller scale production line, so that the cost of production of new products is high,tory burch, the actual operation of a loss, they may even horses in the new production line process strand breaks leaving a financing strategy for diversified business bankruptcy. T in a strategy of pharmaceutical companies plan, first estimated that the project needs to capital costs, combined with their own financial situation, look at the funding can be guaranteed. If the financial security may be a problem, then, determined not to start new projects. Typically, in the pharmaceutical field, the competition between the performance of enterprise technology and price competition. 27 enterprises with advanced technology behind the business more than technology to ensure drug quality, and its cost may be lower. Therefore, the enterprise's core competitiveness of the enterprise reflects the available production technology. Combined with the preceding analysis, we know that corporate diversification strategy should focus on core competitiveness of enterprises to start, then the pharmaceutical companies in the choice of diversification strategies, you should first select and control their own production technology has been closely relevant products. Such as enter a comparison of the chemical structure and synthesis of a similar drug production areas. This diverse business strategy is not only easy to be successful, generating additional revenue, and, because of new production technology to master more comprehensive than the risk of possible / J,. Pharmaceutical prices, during the diversification strategy, they can enter the field of upstream and downstream products, this diversification strategy is known as vertical integration strategies, including forward integration and backward integration strategy, raw material drug companies into the preparation industry is a backward integration strategy, whereas preparation of its raw material drug production enterprises to enter the area known as the forward integration strategy. Vertically integrated business strategy for the implementation of the raw material drug companies, since the use of the drug product production products as raw materials,mbt shoes outlet, thus, reduce the cost, to finished products in the market to enhance competitiveness; raw material drug production enterprises to enter the preparation production areas can increase the added value of products, increase their profit margins. |
|
